Nootropics Index - Save on smarter supplements
Isolated phytochemicals & plant compounds

Theobromine

Theobromine (3,7-dimethylxanthine)

Theobromine is a cocoa alkaloid related to caffeine. In a controlled healthy-adult study, isolated theobromine did not produce a reliable cognitive-performance benefit: lower experimental exposure had limited subjective effects, while higher exposure increased heart rate and unpleasant effects. Compare products by exact theobromine amount, extract standardization, caffeine co-content, and label information.

Isolated CompoundFood DerivedClinical ResearchLimited Human EvidenceDose Dependent EvidenceForm Dependent EvidenceModerate Risk Profile
Updated August 2026/5 min read/8 citations
Reviewed by the NootropicsIndex editorial team.Method: prioritize cited human research and official safety or regulatory sources; compare retailer-listed prices without endorsing products.Affiliate disclosure
01

What is it?

What theobromine is

1

Theobromine is a methylxanthine alkaloid found in cocoa. This profile concerns isolated theobromine powders and capsules, plus products that state a standardized theobromine amount; it is not a guide to caffeine or to general chocolate-health claims.

Cognitive evidence2
In a placebo-controlled healthy-adult study, isolated theobromine did not show a reliable cognitive-performance benefit. The 250 mg dose had limited subjective effects; higher single doses had more unpleasant mood effects and higher heart rate.
02

Names, aliases and forms

Common NameTheobromine
Chemical Names3,7-Dimethylxanthine; 3,7-dimethylpurine-2,6-dione
Cas Number83-67-0
03

Potential effects and evidence map

A placebo-controlled healthy-adult study tested single oral theobromine doses across a low-to-high experimental range against placebo and caffeine. Isolated theobromine showed limited effects at the lower exposure, dose-related unpleasant mood effects at higher exposure, and no reliable cognitive-performance benefit. These acute findings do not establish a routine supplement serving, cycle, or long-term nootropic effect.

Effect domainMagnitudeGrade
Mental energy / wakefulness2
AcuteConfidence: Medium

Acute healthy-adult research does not show a reliable caffeine-like cognitive-performance benefit from isolated theobromine.

Note The 250 mg dose had limited subjective effects; higher doses did not provide a dependable nootropic effect.

1/5
C
Mood / wellbeing2
AcuteConfidence: Medium

The controlled study does not establish a mood benefit from isolated theobromine; unpleasant subjective effects increased at higher doses.

Note The limited low-dose signal was not accompanied by a broader reliable mood pattern.

0/5
C
Focus / attention2
AcuteConfidence: Medium

Controlled acute research does not establish a focus or attention benefit from isolated theobromine.

Note Do not infer a cognitive benefit from its chemical relationship to caffeine.

0/5
C
04

Typical dosages and timing

Not a routine serving recommendation2250-1000 mg

The controlled study tested 250, 500, and 1000 mg as single experimental doses. It did not establish a daily serving, cycle, or long-term supplement plan.

05

Timing & effect horizon

Effect horizonUnknown
Unknown
Half-life3Acute
7.2 hours
Blood-level timing4

In a small absorption study, theobromine concentrations peaked around three hours after a capsule and around two hours after chocolate in the tested protocol. A concentration peak is not the same as a felt onset.

Elimination context3

A pharmacokinetic study in six healthy male volunteers reported a 7.2-hour theobromine The time for blood levels to fall by half during the final elimination phase.Source. This does not establish how long any individual will feel an effect.

06

Safety, side effects and risk profile

Pregnancy evidence gap7
Health Canada stated in 2024 that available information was insufficient for acceptable conditions of use as a supplemental food ingredient and identified reproductive and developmental safety information as a data gap. This is a Canadian regulatory context, not a universal safety conclusion for every product.
Lactation exposure8
LactMed reports that cocoa-derived theobromine can be detected in breastmilk after chocolate. That food-exposure information does not assess concentrated powder or capsule products.
Evidence uncertainty2
Confidence: High

Acute laboratory findings do not establish a routine supplement serving, cycling plan, or long-term safety profile.

Note This evidence gap is disclosed separately and does not itself imply a high adverse-effect risk.

1/5
C
Cardiovascular caution2
Confidence: Medium

The controlled healthy-adult study found dose-related increases in heart rate at higher isolated doses.

Note Extra caution is appropriate for people with cardiovascular conditions or stimulant sensitivity.

3/5
C
Headache / dizziness2
Confidence: Medium

Headache was the most common reported adverse effect in the controlled study, with most reports in the 1000 mg condition.

Note The study was acute and does not provide incidence estimates for routine supplement use.

2/5
C
GI discomfort2
Confidence: Medium

Nausea was reported mainly in the 1000 mg condition, including one vomiting event.

Note This is high-dose study context, not a predicted effect at every listed serving.

2/5
C
Pregnancy / lactation caution8
Confidence: Low

LactMed reports food-derived theobromine in breastmilk after chocolate; it does not assess concentrated powder or capsule products.

Note This lactation exposure context does not establish a safety profile for concentrated products.

2/5
D
Legal / regulatory risk7
Confidence: High

Canada did not accept theobromine as a supplemental ingredient in foods in its 2024 decision because available data were insufficient for acceptable conditions of use.

Note This applies to a Canadian supplemented-food pathway and is not a universal legal conclusion or a statement of U.S. supplement status.

3/5
B
Heart rate and mood2Higher acute doses

In the controlled study, 500 and 1000 mg were associated with dose-related heart-rate increases and more unpleasant subjective effects. That makes concentrated powders and capsules meaningfully different from ordinary cocoa foods.

1000 mg study condition2High-dose study context

Headache was the most common reported adverse effect and nausea was second most common; most reports of both were in the 1000 mg condition, including one vomiting event. This acute study does not predict what will occur at every product serving.

07

Interactions and cautions

Not an interaction study2

The controlled study compared separate theobromine, caffeine, and placebo conditions. It was not designed to establish medicine or multi-stimulant interaction effects.

Ask before use5

FDA advises consumers to speak with a doctor, pharmacist, or other health care professional before deciding to use a dietary supplement.

09

How it compares

Related, not interchangeable2

The same study used caffeine as an active comparison. Caffeine produced clearer stimulant-like mood and reaction-time effects, whereas isolated theobromine did not show the same reliable pattern. Do not assume a cocoa-derived ingredient will act like a caffeine serving.

10

Practical buying and quality notes

  • The current catalog snapshot includes powders and capsules. Compare the stated theobromine amount per serving, do not equate an extract weight with active theobromine, and check whether caffeine is listed separately. Listing counts and products can change.6
11

FAQ

Does theobromine improve focus?

2

Not reliably based on the available controlled healthy-adult study. Isolated theobromine did not show a dependable cognitive-performance benefit, and it was less stimulant-like than the caffeine comparison.

What theobromine amount was studied?

2

Researchers tested single 250, 500, and 1000 mg doses. Those experiments are useful for interpreting evidence and safety signals, but they do not set a routine supplement serving.

How long does theobromine last?

3

One small human pharmacokinetic study reported a 7.2-hour half-life. That helps describe elimination, but it does not predict a personal onset, felt duration, or cycling schedule.

12

References

  1. PubChem Compound Summary for Theobromine, CID 5429.
  2. Baggott MJ, Childs E, Hart AB, et al. Psychopharmacology of theobromine in healthy volunteers. Psychopharmacology. 2013;228(1):109-118.
  3. Lelo A, Birkett DJ, Robson RA, Miners JO. Comparative pharmacokinetics of caffeine and its primary demethylated metabolites paraxanthine, theobromine and theophylline in man. Br J Clin Pharmacol. 1986;22(2):177-182.
  4. Mumford GK, Benowitz NL, Evans SM, et al. Absorption rate of methylxanthines following capsules, cola and chocolate. Eur J Clin Pharmacol. 1996;51(3-4):319-325.
  5. U.S. Food and Drug Administration. Questions and Answers on Dietary Supplements.
  6. NootropicsIndex Theobromine catalog snapshot, checked 2026-08-01.
  7. Health Canada. Decision on theobromine as a supplemental ingredient in foods. 2024.
  8. Drugs and Lactation Database (LactMed). Chocolate. National Library of Medicine. Updated 2024.
Note

This page is informational and summarizes available evidence. It is not medical advice, a recommendation, or a substitute for guidance from a qualified clinician.